Clinical Practice: evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin

The aim of the present study was to investigate long term effects of motor denervation by botulinum toxin complex type A (BoNT/A) from Clostridium Botulinum, on the afferent

BoNT-A is an important part of multimodal management, to support motor development and improve function when the targeted management of spasticity in specific muscle

In the present study, we investigated for the first time the potential direct analgesic effects of one-time BTX-A in the painful area in patients with focal

Efficacy of injections of botulinum toxin-A for improving drooling and quality of life in disabled patients.. Beranger T, Pierache A, Loffer Z, Tiffreau V, Ferri J,

B otulinum toxin type A (BTX-A) is a purified neuro- toxin from the bacterium Clostridium botulinum.. It has numerous medical applications such as treatment of cervical

Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy (UPDATE).. Boyd RN,

OVERALL RATING Good STRENGTHS Provides a broad reference for a wide scope of medical problems WEAKNESSES Attempts to expose the botulinum toxin as a panacea; terminology

of deaths, the facility of the bacterial culture, and the low contamination threshold of a victim. The disease incurred is not person-to-person transmissible. Beer is